President of the Swiss Confederation Visits Lek
His Excellency Joseph Deiss, President of the Swiss Confederation, together with the other members of the Swiss delegation who are on an official visit to Slovenia, visited Lek Pharmaceuticals today. Since 2002, Lek has operated as a part of the Swiss Novartis Group, which is the owner of Lek. Lek’s top management presented the Lek company to the Swiss delegation, including its operations and the Lek Development Center, and concluded the visit with a tour of the Lavička Collection.
The official delegation of the Swiss Confederation under the leadership of the President of the Swiss Confederation Mr. Joseph Deiss was received by President of the Lek Board of Management Metod Dragonja together with other members of the Board of Management. Under the guidance of Dr. Brina Ornik, the Director of Research and Development at Lek, the delegation first toured the Lek Development Center, which is one of competence centers of Sandoz, Novartis generics business. The top-level knowledge and wealth of experience of Lek’s professionals together with the latest technologies and close cooperation with researchers and scientific institutions in Slovenia and around the world enable Lek to be competitive on the global pharmaceutical market.
After touring the Development Center, the Swiss delegation attended a presentation of Lek’s operations, where Metod Dragonja emphasized the importance of Lek and Novartis activities in the regions of Central and Eastern Europe, Southeastern Europe and the Commonwealth of Independent States. Lek, a new Sandoz company, has achieved successful business results and has recently completed two of its largest investment projects in recent times: it has opened new pharmaceuticals plants in Poland and Romania, and has placed itself among the most successful and reputed Slovene companies. Integration with Novartis has opened new doors for Lek on the markets of Western Europe and America.
The Swiss delegation concluded their visit with a tour of the Lavička Collection. This is the only pharmaceutical and medical collection in Slovenia of cultural, educational and scientific importance. It has been proclaimed a cultural monument of national importance. Today the owner of the collection is Lek, which purchased it from the descendants of M.S.PHARM. Bohuslav Lavicka, who was of Czech descent. With his work in the Slovene territory, Lavicka left us the legacy of his exceptional pharmaceutical collection, which reflects wide-ranging knowledge and with its wealth of materials demonstrates the place of the Slovene spiritual area within the European cultural sphere, and especially within its scientific tradition.
For further information please call ++386 1 580 22 43
Katarina Klemenc Dinjaski, Corporate Communications, Lek